Nan Li-Nan Li-PKU Institute of Reproductive & Child Health

Education Background

Aug 2017-present	Assistant professor of Institute of Reproductive and Child Health, Peking University Health Science Center
2012-2017	Ph.D. in Epidemiology, School of Public Health, Peking University Health Science Center
2010-2012	B.S. in the Department of Computer Science & Technology, Peking University
2008-2012	B.S. in School of Basic Medical Science, Peking University Health Science Center

Overall introduction

He currently serves at the Key Laboratory of Reproductive Health, National Health Commission/Key Laboratory of Epidemiology of Major Diseases, Ministry of Education/School of Public Health, Peking University. To date, he has presided over more than 10 projects, funded by the National Natural Science Foundation of China, the Natural Science Foundation of Beijing Municipality, the Young Elite Scientists Sponsorship Program by CAST, et al. He has published more than 60 papers in academic journals, including more than 40 papers as the first/corresponding author in leading journals, such as Environment International (×2) (IF>10), Hypertension, Clinical Nutrition, and Journal of Hypertension (×3). He conducts a series of researches on women's perinatal health and birth defects through employing population-based research design, molecular epidemiology, and animal intervention experiments. He offers undergraduate courses "Introduction to Reproductive Health Epidemiology" and "Basic Introduction to Stata Statistical Software", along with postgraduate courses "Medical Research about Public Data" and "Relevant examples about birth cohort studies"

Main research directions

Epidemiology of reproductive health, Data mining in medical research

Representative scientific research projects

2020-2022	National Nature Science Foundation of China; Project grant: The association of phthalates with hypertensive disorders of pregnancy and its potential mechanisms. 210,000 RMB.
2020-2021	Ministry of Science and Technology of China; Project grant: Study on the Epidemiological Characteristics and Evaluation of Prevention and Control Strategies of the COVID-19 Spreading. 4,000,000 RMB.
2022-2024	Beijing Municipal Natural Science Foundation; Project grant: AHRR methylation mediates polycyclic aromatic hydrocarbons to induce hypertensive disorders of pregnancy through 8-OHdG. 200,000 RMB.
2019-2020	Beijing Municipal Natural Science Foundation; Project grant: The association of polycyclic aromatic hydrocarbons with hypertensive disorders of pregnancy and its potential mechanisms. 90,000 RMB.
2020-2021	Beijing outstanding talent incubation program; Project grant: The association of hydroxy polycyclic aromatic hydrocarbons with hypertensive disorders of pregnancy and its potential mechanisms. 60,000 RMB.
2019-2021	Young Elite Scientist Sponsorship Program by CAST (YESS). 450,000 RMB.
2022-2023	National Clinical Research Center for Obstetrics and Gynecology (Peking University Third Hospital); Project grant: Epidemiology of related domestic violence among Chinese infertile women. 100,000 RMB.
2017-2019	The startup funding from the “Incubation” Program of China and Peking University Health Science Center (no. MU2017YB003).

10 representative papers

(1)	Liu X, Na J, Liu X, Jia X, Ren M, Chen J, Han B, Xu J, Li N, Li Z, Wang B. Co-exposure to phthalates and polycyclic aromatic hydrocarbons and the risk of gestational hypertension in Chinese women. Environment International, 2024, 185: 108562. (IF=11.8)
(2)	Jin M, Chen H, Na J, An H, Li Z, Li N. Passive smoking and insomnia in rural Chinese nonsmoking housewives: An environmental and genetic perspective. Environment International, 2022, 170: 107569. (IF=13.352)
(3)	Li N, Li Z, Ye R, Zhang L, Li H, Zhu Y, Li S, Yang N, Liu J, Ren A. Preconception blood pressure and risk of low birth weight and small for gestational age: a large cohort study in China. Hypertension, 2016, 68(4): 873-9.
(4)	Li N, Li Z, Chen S, Yang N, Ren A, Ye R. Effects of passive smoking on hypertension in rural Chinese nonsmoking women. Journal of Hypertension, 2015, 33(11): 2210-4. [Commented in Journal of Hypertension, 2015, 33(11): 2200-3]
(5)	Li N, Li Z, Ye R, Zhu Y, Li S, Yang N, Zhang L, Li H, Liu J, Ren A. Preconception blood pressure and risk of preterm birth: a large cohort study in China. Journal of Hypertension, 2016, 34(11): 2243-7.
(6)	An H, Jin M, Li Z, Zhang L, Zhang Y, Li H, Liu J, Ye R, Li N. Association of gestational hypertension and preeclampsia with nonsyndromic orofacial clefts in China: a large prospective cohort study. Journal of Hypertension, 2022, 40(7): 1352-8.
(7)	Li N, Li Z*, Ye R, Liu J, Ren A. Impact of periconceptional folic acid supplement on low birth and small for gestational age in China: a large prospective cohort study. Journal of pediatrics, 2017, 187: 105-10.
(8)	Li N, An H, Li Z, Ye R, Zhang L, Li H, Liu J. Preconception blood pressure and risk of gestational hypertension and preeclampsia: A large cohort study in China. Hypertension Research, 2020, 43(9):956-62.
(9)	Chen S^#, Li N^#, Mei Z, Ye R*, Li Z, Liu J, Serdula MK. Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: A randomized clinical trial. Clinical Nutrition, 2019, 38(1): 146-51.
(10)	吴博浩，金楚瑶，王慧英，李楠，李智文. “二孩”政策以来中国北方某三甲医院高龄产妇及产数变化情况分析.中国生育健康杂志, 2018, 29: 201-4.